Hepatocellular Carcinoma: Portuguese Data in Chronic Hepatitis B Patients on Antiviral Therapy and Treatment Results With Sorafenib

Hepatocellular Carcinoma: Portuguese Data in Chronic Hepatitis B Patients on Antiviral Therapy and Treatment Results With Sorafenib

Saved in:

Bibliographic Details
Main Author:	Simão,Adélia
Format:	Digital revista
Language:	English
Published:	Sociedade Portuguesa de Gastrenterologia 2016
Online Access:	http://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452016000500001
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prevention of hepatocellular carcinoma with antiviral therapy
by: Di Bisceglie,A M
Published: (2018)

Overall survival predictors in hepatocellular carcinoma patients treated with sorafenib
by: Ferreira,Caroline Petersen da Costa, et al.
Published: (2020)

Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma
by: Marta,Guilherme Nader, et al.
Published: (2021)

Perfusion Magnetic Resonance as a Biomarker for Sorafenib-Treated Advanced Hepatocellular Carcinoma: A Pilot Study
by: Campos,Marta, et al.
Published: (2019)

The Impact of Early Dermatologic Events in the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib
by: Branco,Fernanda, et al.
Published: (2017)

The Direct-Acting Antivirals for Hepatitis C Virus and the Risk for Hepatocellular Carcinoma
by: Chinchilla-López,Paulina, et al.
Published: (2017)

Hepatocellular Carcinoma Treatment With Sorafenib: Real-Life Evaluation of Prognostic Factors and a Practical Clue for Patient Management
by: Cardoso,Helder, et al.
Published: (2016)

Access to antiviral therapy for chronic hepatitis B during COVID-19
by: Bertolli¹,Marilia Rocha, et al.
Published: (2022)

Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellular carcinoma cells
by: Zhang,Yafei, et al.
Published: (2012)

Treating Advanced Hepatocellular Carcinoma with Sorafenib: A 10-Year Single Center Experience
by: Ramos,José Presa, et al.
Published: (2023)

Towards the elimination of hepatitis B and hepatocellular carcinoma
by: Spearman,C W
Published: (2018)

Combination of TACE and Sorafenib Improves Outcomes in BCLC Stages B/C of Hepatocellular Carcinoma: A Single Centre Experience
by: Varghese,Joy, et al.
Published: (2017)

Hepatocellular carcinoma in patients without advanced fibrosis after eradication of HCV with antiviral treatment
by: Sánchez-Torrijos,Yolanda, et al.
Published: (2017)

In vivo inhibitory effect of suberoylanilide hydroxamic acid combined with sorafenib on human hepatocellular carcinoma cells
by: Hao,Dalin, et al.
Published: (2020)

Locoregional therapies for the treatment of locally advanced hepatocellular carcinoma
by: Motta-Leal-Filho,Joaquim Maurício da
Published: (2021)

Occult hepatitis B virus infection in patients with chronic liver disease due to hepatitis C virus and hepatocellular carcinoma in Brazil
by: Branco,Fernanda, et al.
Published: (2007)

A practical guide for antiviral therapy of chronic Hepatitis C
by: Velosa,José, et al.
Published: (2014)

Patients' preferences for treatment with the new direct acting antiviral therapies for chronic hepatitis C virus infection
by: Simón,MA, et al.
Published: (2021)

Patients' preferences for treatment with the new direct acting antiviral therapies for chronic hepatitis C virus infection
by: Simón,MA, et al.
Published: (2021)

Hepatocellular carcinoma in patients with B and C virus hepatitis without cirrhosis
by: Carvalho,Kellyane Santana Dias, et al.
Published: (2017)

Chronic hepatitis C: hepatic iron content does not correlate with response to antiviral therapy
by: Pereira,Patricia da Silva Fucuta, et al.
Published: (2009)

Oscillations in serum ferritin associated with antiviral therapy in chronic hepatitis C
by: Ladero,J. M., et al.
Published: (2009)

Hepatitis C virus and hepatocellular carcinoma
by: Garrido-Serrano,Antonio, et al.
Published: (2011)

Eczema craquelé associated with antiviral treatment for chronic hepatitis C
by: Vale,Edla Polsinelli Bedin Mascarin do, et al.
Published: (2017)

Hepatic fibrosis in patients with chronic hepatitis C assessed by transient elastography: implications for determining the efficacy of antiviral therapy
by: Mendoza,J., et al.
Published: (2010)

Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C
by: Blanc, Jean-Frédéric, et al.

Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Third Generation Nucleos(t)ides Analogs: Risk Factors and Performance of a Risk Score
by: Magalhães-Costa,Pedro, et al.
Published: (2016)

YMDD motif mutations in chronic hepatitis B antiviral treatment naïve patients: a multi-center study
by: Tan,You-Wen, et al.
Published: (2012)

MicroRNA-92b augments sorafenib resistance in hepatocellular carcinoma via targeting PTEN to activate PI3K/AKT/mTOR signaling
by: Cheng,Zhouyang, et al.
Published: (2021)

Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes
by: Mello,Francisco Campello do Amaral, et al.
Published: (2012)

Liver metastasis from neuroendocrine carcinoma after the use of the new direct-action antivirals against hepatitis C virus in a patient with past history of hepatocellular carcinoma
by: Caldas,María, et al.
Published: (2017)

SUSTAINED VIROLOGIC RESPONSE RATE IN CHRONIC HEPATITIS C PATIENTS THROUGH DIRECT-ACTING ANTIVIRALS THERAPY
by: TORRES,Andréa Delfino, et al.
Published: (2019)

Diagnosis, staging and treatment of hepatocellular carcinoma
by: França,A.V.C., et al.
Published: (2004)

Causes of treatment failure for hepatitis C in the era of direct-acting antiviral therapy
by: Cabezas,Joaquín, et al.
Published: (2016)

HEPATOCELLULAR CARCINOMA IN A NON-CIRRHOTIC PATIENT WITH SUSTAINED VIROLOGICAL RESPONSE AFTER HEPATITIS C TREATMENT
by: MATTOS,Angelo Alves de, et al.
Published: (2015)

Treatment of chronic hepatitis C in treatment-naïve patients
by: Ferreira,Marcelo Simão
Published: (2007)

Preventing hepatitis B and hepatocellular carcinoma in South Africa: The case for a birth-dose vaccine
by: Spearman,C W N, et al.
Published: (2014)

B-RAF PROTEIN IMMUNOEXPRESSION IN HEPATOCELLULAR CARCINOMA DUE TO HEPATITIS C VIRUS RELATED CIRRHOSIS
by: GARCIA,Paula Piedade, et al.
Published: (2021)

Risk Factors for Prognosis of Hepatocellular Carcinoma After Curative Resection In Patients with Low Hepatitis B Viral Load
by: Qu,Li-Shuai, et al.
Published: (2017)

Progress in Hepatocellular Carcinoma Treatment [electronic resource] /
by: Okita, Kiwamu. editor., et al.
Published: (2000)

Resource Map